SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    O’Connor DW, Rosewarne R, Bruce A. Depression in primary care. 2: general practitioners’ recognition of major depression in elderly patients. Int Psychogeriatr 2001; 13: 367374.
  • 2
    Fujita Y, Inoue K, Takakuwa T et al. [Senile depression.] St Marianna Med Res 2005; 5: 3337. (In Japanese.)
  • 3
    American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 4th edn text revision. Washington DC: APA, 2000.
  • 4
    Tanii H, Takeda M. [Major depression.] Nihon Risho Zoukango 2003; 61: 384388. (In Japanese.)
  • 5
    Londborg PD, Smith WT, Glaudin V et al. Short-term cotherapy with clonazepam and fiuoxetine: anxiety, sleep disturbance and core symptoms of depression. J Affect Disord 2000; 61: 7379.
  • 6
    Winkler D, Willeit M, Wolf R et al. Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder. Eur Neuropsychopharm 2003; 13: 129134.
  • 7
    Haefely W. The biological basis of benzodiazepine actions. J Psychoactive Drugs 1983; 15: 1939.
  • 8
    Lima L. Region-selective reduction of brain serotonin turnover rate and serotonin turnover rate and serotonin agonist-induced behavior in mice treated with clonazepam. Pharmacol Biochem Behav 1991; 39: 671676.
  • 9
    Browne TR. Clonazepam. N Engl J Med 1978; 299: 812816.
  • 10
    Valenca AM, Nardi AE, Nascimento I et al. Double-blind clonazepam vs placebo in panic disorder treatment. Arq Neuropsiquiatr 2000; 58: 10251029.
  • 11
    Worthington JJ, Pollack MH, Otto MW et al. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull 1998; 34: 199205.
  • 12
    Adler LW. Mixed bipolar disorders responsive to lithium and clonazepam. J Clin Psychiatry 1986; 47: 4950.
  • 13
    Chouinard G, Young SN, Annable L. Antimanic effects of clonazepam. Biol Psychiatry 1983; 18: 451466.
  • 14
    Pande A. Clonazepam treatment of atypical bipolar disorder. Psychosomatics 1988; 29: 333335.
  • 15
    Devane LC, Ware RM, Lydiard BR. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam. Psychopharmacol Bull 1991; 27: 463473.
  • 16
    Herman JB, Brotman AW, Rosenbaum JF. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. J Clin Psychiatry 1987; 48: 2228.
  • 17
    Pecknold JC. Discontinuation reactions to alprazolam in panic disorder. J Psychiatr Res 1990; 27: 155170.
  • 18
    Morishita S. [Clonazepam supplementation for prolonged depression: clinical analysis of 100 cases.] Nihon Shinkeiseishin Yakurigakuzassi 2002; 22: 97101. (In Japanese.)
  • 19
    Shirakawa O. [The fact of pharmacotherapy of senile depression.] Geriatric Med 2002; 40: 451459. (In Japanese.)